Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Ugeskrift for Laeger
|
June 10, 1996
[Use of fresh frozen plasma in patient treatment. Indications illustrated by a literature review and a study of practice at a university hospital]
C Lahrmann, K Højlund, T Kristensen, et al.
Diabetes, Obesity & Metabolism
|
February 21, 2008
Adiponectin and its response to thiazolidinediones are associated with insulin-mediated glucose metabolism in type 2 diabetic patients and their first-degree relatives
V Hulstrøm, K Højlund, J Vinten, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
October 28, 2014
Glutamic acid decarboxylase autoantibody-positivity post-partum is associated with impaired β-cell function in women with gestational diabetes mellitus
T P Lundberg, K Højlund, L S Snogdal, et al.
European Journal of Clinical Investigation
|
January 22, 2003
Effect of insulin on protein phosphatase 2A expression in muscle in type 2 diabetes
K Højlund, M Poulsen, P Staehr, et al.
Diabetes, Obesity & Metabolism
|
June 18, 2009
Maximal lipid oxidation in patients with type 2 diabetes is normal and shows an adequate increase in response to aerobic training
M Mogensen, B F Vind, K Højlund, et al.
Ugeskrift for Laeger
|
December 9, 1996
[Rational transfusion therapy. A study of transfusion practice and possibilities of optimization in elective coronary bypass surgery]
K Højlund, L I Andersen, M S Hüttel, et al.
Diabetologia
|
July 31, 2007
Liver X receptor antagonist reduces lipid formation and increases glucose metabolism in myotubes from lean, obese and type 2 diabetic individuals
E T Kase, G H Thoresen, S Westerlund, et al.
Diabetologia
|
April 13, 2006
Reduced plasma adiponectin concentrations may contribute to impaired insulin activation of glycogen synthase in skeletal muscle of patients with type 2 diabetes
K Højlund, J Frystyk, K Levin, et al.
Diabetologia
|
June 9, 2006
Partial rescue of in vivo insulin signalling in skeletal muscle by impaired insulin clearance in heterozygous carriers of a mutation in the insulin receptor gene
K Højlund, J F P Wojtaszewski, J Birk, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
August 25, 2012
Osteoprotegerin levels decrease during testosterone therapy in aging men and are associated with changed distribution of regional fat
L Frederiksen, D Glintborg, K Højlund, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Ugeskrift for Laeger
|
June 10, 1996
[Use of fresh frozen plasma in patient treatment. Indications illustrated by a literature review and a study of practice at a university hospital]
C Lahrmann, K Højlund, T Kristensen, et al.
Diabetes, Obesity & Metabolism
|
February 21, 2008
Adiponectin and its response to thiazolidinediones are associated with insulin-mediated glucose metabolism in type 2 diabetic patients and their first-degree relatives
V Hulstrøm, K Højlund, J Vinten, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
October 28, 2014
Glutamic acid decarboxylase autoantibody-positivity post-partum is associated with impaired β-cell function in women with gestational diabetes mellitus
T P Lundberg, K Højlund, L S Snogdal, et al.
European Journal of Clinical Investigation
|
January 22, 2003
Effect of insulin on protein phosphatase 2A expression in muscle in type 2 diabetes
K Højlund, M Poulsen, P Staehr, et al.
Diabetes, Obesity & Metabolism
|
June 18, 2009
Maximal lipid oxidation in patients with type 2 diabetes is normal and shows an adequate increase in response to aerobic training
M Mogensen, B F Vind, K Højlund, et al.
Ugeskrift for Laeger
|
December 9, 1996
[Rational transfusion therapy. A study of transfusion practice and possibilities of optimization in elective coronary bypass surgery]
K Højlund, L I Andersen, M S Hüttel, et al.
Diabetologia
|
July 31, 2007
Liver X receptor antagonist reduces lipid formation and increases glucose metabolism in myotubes from lean, obese and type 2 diabetic individuals
E T Kase, G H Thoresen, S Westerlund, et al.
Diabetologia
|
April 13, 2006
Reduced plasma adiponectin concentrations may contribute to impaired insulin activation of glycogen synthase in skeletal muscle of patients with type 2 diabetes
K Højlund, J Frystyk, K Levin, et al.
Diabetologia
|
June 9, 2006
Partial rescue of in vivo insulin signalling in skeletal muscle by impaired insulin clearance in heterozygous carriers of a mutation in the insulin receptor gene
K Højlund, J F P Wojtaszewski, J Birk, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
August 25, 2012
Osteoprotegerin levels decrease during testosterone therapy in aging men and are associated with changed distribution of regional fat
L Frederiksen, D Glintborg, K Højlund, et al.
Page
of 4